ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types

Clinical Endocrinology

Volumn 77, Issue 6, 2012, Pages 871-876

  Mathioudakis, Nestoras ^a   Thapa, Sritika ^a   Wand, Gary S ^a   Salvatori, Roberto ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CORTICOTROPIN; HYDROCORTISONE; LEVOTHYROXINE; PROLACTIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; FOLLOW UP; HORMONE RELEASE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NONFUNCTIONING PITUITARY ADENOMA; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; REMISSION; RETROSPECTIVE STUDY; SALIVA; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME;

ACTH-SECRETING PITUITARY ADENOMA; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHYROIDISM; MALE; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; SALIVA; THYROTROPIN; THYROXINE;

EID: 84869077860     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04442.x     Document Type: Article

References (21)

1. Freda, P.U., Beckers, A.M., Katznelson, L., et al,. (1996) Pituitary incidentaloma: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 96, 894-904.
2. Arafah, B.M., Prunty, D., Ybarra, J., et al,. (2000) The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. Journal of Clinical Endocrinology & Metabolism, 85, 1789-1793. (Pubitemid 32269277)
3. Cury, M.L., Fernandes, J.C., Machado, H.R., et al,. (2009) Non-functioning pituitary adenomas: clinical feature, laboratorial and imaging assessment, therapeutic management and outcome. Arquivos Brasileiros de Endocrinologia e Metabologia, 53, 31-39.
4. Yuen, K.C., Cook, D.M., Sahasranam, P., et al,. (2008) Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels. Clinical Endocrinology, 69, 292-298. (Pubitemid 352009029)
5. Ferrante, E., Ferraroni, M., Castrignano, T., et al,. (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. European Journal of Endocrinology, 155, 823-829. (Pubitemid 46040620)
6. Anagnostis, P., Adamidou, F., Polyzos, S.A., et al,. (2011) Pituitary incidentalomas: a single-centre experience. International Journal of Clinical Practice, 65, 172-177.
7. Haugen, B.R., (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Practice & Research: Clinical Endocrinology & Metabolism, 23, 793-800.
8. Nicoloff, J.T., Fisher, D.A., &, Appleman Jr, M.D., (1970) The role of glucocorticoids in the regulation of thyroid function in man. The Journal of Clinical Investigation, 49, 1922-1929.
9. Wilber, J.F., &, Utiger, R.D., (1969) The effect of glucocorticoids on thyrotropin secretion. The Journal of Clinical Investigation, 48, 2096-2103.
10. Samuels, M.H., &, McDaniel, P.A., (1997) Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research center study. The Journal of Clinical Endocrinology and Metabolism, 82, 3700-3704. (Pubitemid 27509358)
11. Chopra, I.J., Williams, D.E., Orgiazzi, J., et al,. (1975) Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3',5-triiodothyronine (T3). Journal of Clinical Endocrinology & Metabolism, 41, 911-920.
12. Alkemade, A., Unmehopa, U.A., Wiersinga, W.M., et al,. (2005) Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. Journal of Clinical Endocrinology & Metabolism, 90, 323-327. (Pubitemid 40116675)
13. Roelfsema, F., Pereira, A.M., Biermasz, N.R., et al,. (2009) Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing's syndrome. European Journal of Endocrinology, 161, 695-703.
14. Veldman, R.G., Frolich, M., Pincus, S.M., et al,. (2000a) Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing disease after clinically successful transsphenoidal adenomectomy. Journal of Clinical Endocrinology & Metabolism, 85, 4039-4046. (Pubitemid 32055350)
15. Kuwayama, A., Kageyama, N., Nakane, T., et al,. (1981) Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing disease. Journal of Clinical Endocrinology & Metabolism, 53, 165-173. (Pubitemid 13245399)
16. Paoletta, A., Arnaldi, G., Papa, R., et al,. (2011) Intrapituitary cytokines in Cushing disease: do they play a role? Pituitary, 14, 236-241.
17. Pappa, T.A., Vagenakis, A.G., &, Alevizaki, M., (2011) The nonthyroidal illness syndrome in the non-critically ill patient. European Journal of Clinical Investigation, 41, 212-220.
18. Kristo, C., Godang, K., Ueland, T., et al,. (2002) Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome. European Journal of Endocrinology, 146, 389-395. (Pubitemid 34257650)
19. Carlson, H.E., (2011) Drugs and pituitary function. In:, S. Melmed, ed. Pituitary. Elsevier Inc., Oxford, 413-430, 421.
20. Veldman, R.G., Frolich, M., Pincus, S.M., et al,. (2000b) Growth hormone and prolactin are secreted more irregularly in patients with Cushing disease. Clinical Endocrinology, 52, 625-632. (Pubitemid 30337089)
21. Orija, I.B., Weil, R.J., &, Hamrahian, A.H., (2012) Pituitary incidentaloma. Best Practice & Research: Clinical Endocrinology & Metabolism, 26, 47-68.